Table 1 Clinicopathological data of the studied cohort
Parameter | Number (n) | Percent (%) | ||||
|---|---|---|---|---|---|---|
FIGO 2014 Classification | ||||||
 Stage IA | 0 | 0% | ||||
 IB | 0 | 0% | ||||
 IC | 20 | 35.7% | ||||
 Stage IIA | 0 | 0% | ||||
 IIB | 11 | 19.6% | ||||
 IIC | 6 | 12.5% | ||||
 Stage IIIA | 0 | 0% | ||||
 IIIB | 8 | 14.2% | ||||
 IIIC | 7 | 12.5% | ||||
 Stage IV | 4 | 7.14% | ||||
Age (years) | ||||||
 < 50 | 29 | 52% | ||||
 > 50 | 27 | 48% | ||||
Parity | ||||||
 Nulliparous | 2 | 3.6% | ||||
 Multipara | 54 | 96.4% | ||||
Menopausal status | ||||||
 Post-menopausal | 15 | 26.8% | ||||
 Premenopausal | 41 | 73.2% | ||||
Organ metastasis | ||||||
 Present | 4 | 7.14% | ||||
 Absent | 52 | 92.9% | ||||
Lymph node metastasis | ||||||
 Present | 19 | 33.9% | ||||
 Absent | 37 | 66.1% | ||||
Cytology types | Number | Percent | ||||
 Mucinous | 23 | 41.1% | ||||
 Serous | 27 | 48.2% | ||||
 Endometroid | 0 | 0% | ||||
 Clear cell carcinoma | 6 | 10.7% | ||||
 Brenner | 0 | 0% | ||||
 Small cell | 0 | 0% | ||||
Tumor markers | High | Normal | Not available | |||
| Â | N | % | N | % | N | % |
 CA125 | 50 | 89% | 6 | 11% | 0 | 0 |
 CEA | 46 | 82% | 10 | 18% | 0 | 0 |
 CA19.9 | 13 | 23% | 24 | 43% | 19 | 34% |